Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D02011 (
FAD
)
5,530
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bifunctional
FAD
synthases (FADSs) catalyze FMN (flavin mononucleotide) and
FAD
(flavinadenine dinucleotide) biosynthesis at their C-riboflavin kinase (RFK) and N-FMN:adenylyltransferase (FMNAT) modules, respectively. Biophysical properties and requirements for their FMNAT activity differ among species. Here, we evaluate the relevance of the integrity of the binding site of the isoalloxazine of flavinic substrates for FMNAT catalysis in
Corynebacterium ammoniagenes
FADS (
Ca
FADS). We have substituted
P56
and P58, belonging to a conserved motif, as well as L98. These residues shape the isoalloxazine FMNAT site, although they are not expected to directly contact it. All substitutions override enzyme ability to transform substrates at the FMNAT site, although most variants are able to bind them. Spectroscopic properties and thermodynamic parameters for the binding of ligands indicate that mutations alter their interaction modes. Substitutions also modulate binding and kinetic properties at the RFK site, evidencing the crosstalk of different protomers within
Ca
FADS assemblies during catalysis. In conclusion, despite the FMNAT site for the binding of substrates in
Ca
FADS appearing as a wide open cavity, it is finely tuned to provide the competent binding conformation of substrates. In particular,
P56
, P58 and L98 shape the isoalloxazine site to place the FMN- and
FAD
-reacting phosphates in optimal geometry for catalysis.
...
PMID:Specific Features for the Competent Binding of Substrates at the FMN Adenylyltransferase Site of FAD Synthase from
Corynebacterium ammoniagenes
. 3161 72